Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow HUM
Humana Inc. (HUM) Price to free cash flow
As of 16 October 2026, Humana Inc. (HUM) trades at a price to free cash flow of 25.2×. Over the past ten years it has ranged from 0.0× (December 2024) to 385× (July 2015); the current reading is higher than 73% of that period. That is above the Healthcare Plans industry median of 11.8× and above the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 77.5× | 507.67% |
| FY2024 | 12.8× | (30.18%) |
| FY2023 | 18.3× | 0.12% |
| FY2022 | 18.2× | (71.08%) |
| FY2021 | 63.1× | 443.90% |
| FY2020 | 11.6× | 7.39% |
| FY2019 | 10.8× | (57.18%) |
| FY2018 | 25.2× | 144.75% |
| FY2017 | 10.3× | (50.79%) |
| FY2016 | 20.9× | (72.83%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 24.2× | 50.11% |
| Mar 2026 | 16.1× | (79.22%) |
| Dec 2025 | 77.5× | 284.97% |
| Sep 2025 | 20.1× | 67.13% |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.2× |
| CNC Centene Corporation compare | 3.8× |
| CI Cigna Group compare | 8.7× |
| CVS CVS Health Corporation compare | 10.0× |
| ELV Elevance Health, Inc. compare | 14.8× |
| UNH UnitedHealth Group Incorporated compare | 15.9× |
| HUM Humana Inc. | 25.2× |
| CLOV Clover Health Investments, Corp. compare | 31.6× |
| MOH Molina Healthcare, Inc compare | 39.1× |
| Healthcare Plans industry median | 11.8× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement